Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 26 Procedure and deadlines

1 The eth­ics com­mit­tee shall ac­know­ledge re­ceipt of the ap­plic­a­tion with­in 7 days and no­ti­fy the in­vest­ig­at­or of any form­al de­fi­cien­cies in the ap­plic­a­tion doc­u­ments.

2 It shall reach a de­cision with­in 30 days of ac­know­ledge­ment of re­ceipt of the form­ally cor­rect ap­plic­a­tion doc­u­ments.

3 If the eth­ics com­mit­tee re­quests ad­di­tion­al in­form­a­tion in ac­cord­ance with Art­icle 24 para­graph 2, the clock shall be stopped un­til this in­form­a­tion has been re­ceived.

4 It shall in­form the Agency of its de­cision in the case of Cat­egory B and C clin­ic­al tri­als.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden